-+ 0.00%
-+ 0.00%
-+ 0.00%

ENGENE THERAPEUTICS INC - 55% EXPERIENCED TREATMENT-RELATED ADVERSE EVENTS OF DETALIMOGENE, MOSTLY MILD

Reuters·05/07/2026 11:00:04

Please log in to view news